Literature DB >> 9144363

Heterogeneity of cell-associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry.

B Poutrel1, P Rainard, P Sarradin.   

Abstract

It was reported previously that two capsular polysaccharides, types 5 and 8 (CP5 and CP8), account for 70 to 80% of Staphylococcus aureus strains isolated from human and animal sources. The capsular material has been shown to play a part in virulence and in resistance to phagocytosis. With a view to investigating the role that CP plays in pathogenicity or protection, relative measurement of cell-associated CP is desirable. Flow cytometry, which permits the analysis of individual bacteria, was used to that end. Thirty isolates expressing CP5, of human (n = 7) and animal (cow, n = 11; goat, n = 3; swine, n = 3; hen, n = 3; and rabbit, n = 3) origin, were cultivated on either brain heart infusion agar (BHI) or modified medium 110 (mod 110) agar. Staphylococci were incubated with a mouse anti-CP5 monoclonal antibody (an immunoglobulin M, which does not react with staphylococcal protein A) and then stained with a fluorescein-labeled anti-murine antibody. The bacteria were washed, sonicated, and analyzed by flow cytometry. Except for three isolates, the expression of cell-bound CP5 was higher when bacteria were cultivated on mod 110 than when they were cultivated on BHI. We found a wide intraisolate phenotypic heterogeneity in surface-exposed CP5 in many strains, which appeared as mixtures of stained and unstained bacteria. Four main patterns could be distinguished on the basis of the distribution of the fluorescence of individual bacteria within the strain population as a function of growth medium. Great variations in both percentages of stained bacteria and fluorescence intensity were recorded among strains regardless of their origin. Flow cytometry analysis provided information on both the relative amounts and the distribution patterns of the surface expression of CP. This information is potentially useful for the evaluation of the part played by the capsule in the interaction of bacteria with host cells or for the study of the activities of antibodies to this target antigen, such as opsonization or prevention of adherence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144363      PMCID: PMC170518          DOI: 10.1128/cdli.4.3.275-278.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  26 in total

1.  Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains.

Authors:  B Poutrel; F B Gilbert; M Lebrun
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

2.  Fluorescence-activated cell sorter analysis of binding by lipopolysaccharide-specific monoclonal antibodies to gram-negative bacteria.

Authors:  M E Evans; M Pollack; N J Hardegen; N L Koles; G Guelde; J K Chia
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

3.  Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide-ovalbumin conjugate.

Authors:  F B Gilbert; B Poutrel; L Sutra
Journal:  Vaccine       Date:  1994-03       Impact factor: 3.641

4.  Adherence and surface properties of buoyant density subpopulations of group B streptococci, type III.

Authors:  M Granlund-Edstedt; M Sellin; A Holm; S Hakansson
Journal:  APMIS       Date:  1993-02       Impact factor: 3.205

5.  Staphylococcus aureus growth and type 5 capsular polysaccharide production in synthetic media.

Authors:  W T Stringfellow; B Dassy; M Lieb; J M Fournier
Journal:  Appl Environ Microbiol       Date:  1991-02       Impact factor: 4.792

6.  Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  S Xu; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

Authors:  R A Bowden; A Cloeckaert; M S Zygmunt; S Bernard; G Dubray
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Type 5 and 8 capsular polysaccharides are expressed by Staphylococcus aureus isolates from rabbits, poultry, pigs, and horses.

Authors:  B Poutrel; L Sutra
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus.

Authors:  J C Lee; S Takeda; P J Livolsi; L C Paoletti
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.

Authors:  P Rainard; P Sarradin; B Poutrel
Journal:  Microb Pathog       Date:  1994-05       Impact factor: 3.738

View more
  10 in total

1.  Estimation of Staphylococcus aureus growth parameters from turbidity data: characterization of strain variation and comparison of methods.

Authors:  R Lindqvist
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

2.  Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin.

Authors:  Anders Krarup; Uffe B Skov Sørensen; Misao Matsushita; Jens C Jensenius; Steffen Thiel
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence.

Authors:  Andrew Watts; Danbing Ke; Qun Wang; Anil Pillay; Anne Nicholson-Weller; Jean C Lee
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Staphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitro.

Authors:  Annette H Kampen; Tore Tollersrud; Arve Lund
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase.

Authors:  P Pöhlmann-Dietze; M Ulrich; K B Kiser; G Döring; J C Lee; J M Fournier; K Botzenhart; C Wolz
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Characterization of the structure and biological functions of a capsular polysaccharide produced by Staphylococcus saprophyticus.

Authors:  Sunny Park; Kathryn A Kelley; Evgeny Vinogradov; Robert Solinga; Christopher Weidenmaier; Yoshiki Misawa; Jean C Lee
Journal:  J Bacteriol       Date:  2010-07-16       Impact factor: 3.490

7.  Capsule expression and genotypic differences among Staphylococcus aureus isolates from patients with chronic or acute osteomyelitis.

Authors:  Santiago M Lattar; Lorena P N Tuchscherr; Roberto L Caccuri; Daniela Centrón; Karsten Becker; Claudio A Alonso; Claudia Barberis; Graciela Miranda; Fernanda R Buzzola; Christof von Eiff; Daniel O Sordelli
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

Review 8.  Staphylococcus aureus capsular polysaccharides.

Authors:  Katherine O'Riordan; Jean C Lee
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 9.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

10.  Genotypic and phenotypic detection of capsular polysaccharides in Staphylococcus aureus isolated from bovine intramammary infections in Argentina.

Authors:  C Camussone; P Rejf; N Pujato; A Schwab; I Marcipar; L F Calvinho
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.